Chronic Hepatitis C in PWIDs, Treat or Not To Treat
نویسندگان
چکیده
منابع مشابه
Acute hepatitis C: to treat or not to treat.
Although no randomized controlled trials have addressed this question, I recommend a 3to 6-month course of peginterferon-based therapy (with or without ribavirin) in those patients who have failed to clear acute infection. Success rates in this setting (ie, rates of sustained viral clearance) approach 90%. The importance of early treatment is clear: these success rates vastly eclipse those seen...
متن کاملPediatric hepatitis C infection: to treat or not to treat...what's the best for the child?
OBJECTIVES Pediatric hepatitis C mainly occurs through mother to child transmission, to date. Children usually present a mild disease, but they are not spared from its long-term complications. Thus this infection cannot be underestimated in children and intervention is necessary. Current treatment is based on the administration of pegylated-interferon associated with ribavirin, but few studies ...
متن کاملDistress: to treat or not to treat?
In one of our research group meetings, we took an informal poll to find out who would prescribe a benzodiazepine to someone who was acutely grieving, felt anxious, was experiencing some insomnia, and wanted relief from distress. The younger among us mostly would prescribe while those of us who are grizzled would mostly refrain from doing so. Coincidentally, within the next week, one of my patie...
متن کامل[Fever : to treat or not to treat ?]
Fever is routinely faced during medical practice. Although it is part of the immune response against pathogens, it is often seen as deleterious and a source of discomfort leading to the use of antipyretic drugs. However, few clinical data support this common practice. On the contrary, to date, results tilt in favor of the beneficial effect of fever, such as a better immune response and inhibiti...
متن کاملManagement of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Despite a decline in cases of acute hepatitis B and the low hepatitis B virus (HBV) chronicity rates in adults, still some patients progress to HBV-related fulminant liver failure. In this review, we discuss treatment options that may prevent the progression of severe acute hepatitis B to fulminant liver failure and death. In severe acute HBV with prolonged prothrombin time and increased biliru...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Liver Research, Disorders & Therapy
سال: 2017
ISSN: 2471-1381
DOI: 10.15406/jlrdt.2017.03.00060